ZK-813039

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZK-813039
Drug Alias NameZK-81303DE-00684
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncBayer AG
Active IndicationsN/A
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A